Nicotine Lozenge
Product Images NDC 70000-0562

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Nicotine (NDC 70000-0562). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health (leader) 70000, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nicotine Polacrilex Usp, 2 mg (Nicotine 2 mg Mint Maxi Lozenges Rub 1)

Nicotine Polacrilex Usp, 2 mg (Nicotine 2 mg Mint Maxi Lozenges Rub 1)
This is a drug fact sheet for nicotine lozenges containing 2 mg of nicotine polacrilex. The purpose of the lozenge is to help stop smoking, particularly for those who smoke their first cigarette more than thirty minutes after waking up. The box contains 72 lozenges with a mint flavor, and user instructions are included. The product contains the same active ingredient as Nicorette lozenges. The document includes recommendations for success in quitting smoking, such as being motivated, using at least nine lozenges per day for the first week, using the lozenges for a full 12 weeks, and using a support program as directed in the guide provided. There is also a disclaimer, stating that the product is not for sale in vending machines and must be acquired from a source where proof of age can be verified. The text also includes contact information for questions or comments about the product.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.